Combining phage display and screening of cDNA expression libraries:: A new approach for identifying the target antigen of an scFv preselected by phage display

被引:10
作者
Barth, S
Weidenmüller, U
Tur, MK
Schmidt, MFG
Engert, A
机构
[1] Univ Cologne, Dept Internal Med 1, Lab Immunotherapy, D-50931 Cologne, Germany
[2] Univ Berlin, Dept Vet Sci, Inst Immunol & Mol Biol, D-10117 Berlin, Germany
关键词
phage display; tumor antigens; cDNA expression;
D O I
10.1006/jmbi.2000.4038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A potential method for identifying new tumor-specific antibody structures as well as tumor-associated antigens is by selecting scFv phage libraries on tumor cells. This phage display technique involves multiple rounds of phage binding to target cells, washing to remove non-specific phage and elution to retrieve specific binding phage. Although the binding properties of an isolated tumor-specific scFv can be evaluated by ELISA, FAGS and immunohistochemistry, it still remains a challenge to define the corresponding antigen. Here, we provide evidence that the target antigen of a given scFv displayed on phages can be detected in an immobilized lambda phage cDNA expression library containing thousands of irrelevant clones. The library contained CD30-negative breast-cancer specific cDNA as well as human CD30 receptor cDNA. The interaction of anti-CD30 scFv phages and their target antigen after blotting onto nitrocellulose filters was documented under defined conditions. Screening of different ratios between CD30 receptor and breast cancer specific clones (1:1 and 1:200) revealed that the CD30 antigen could be detected by anti-CD30 scFv phages using at least 5 x 10(12) plaque forming units of filamentous phages per blot These investigations demonstrate that it is possible to detect the target antigen of a preselected scFv displayed on filamentous phages in lambda phage cDNA expression libraries. (C) 2000 Academic Press.
引用
收藏
页码:751 / 757
页数:7
相关论文
共 20 条
[1]   Comparison of fusion phage libraries displaying V-H or single-chain Fv antibody fragments derived from the antibody repertoire of a vaccinated melanoma patient as a source of melanoma-specific targeting molecules [J].
Cai, XH ;
Garen, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (17) :9261-9266
[2]   BACTERIOPHAGE-LAMBDA AS A CLONING VECTOR [J].
CHAUTHAIWALE, VM ;
THERWATH, A ;
DESHPANDE, VV .
MICROBIOLOGICAL REVIEWS, 1992, 56 (04) :577-591
[3]   Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity [J].
Chowdhury, PS ;
Viner, JL ;
Beers, R ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :669-674
[4]   CHROMOGENIC IMMUNODETECTION OF HUMAN-SERUM ALBUMIN AND ALPHA-L-FUCOSIDASE CLONES IN A HUMAN HEPATOMA CDNA EXPRESSION LIBRARY [J].
DEWET, JR ;
FUKUSHIMA, H ;
DEWJI, NN ;
WILCOX, E ;
OBRIEN, JS ;
HELINSKI, DR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1984, 3 (06) :437-447
[5]   Strategies for selection of antibodies by phage display [J].
Griffiths, AD ;
Duncan, AR .
CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (01) :102-108
[6]  
Henderikx P, 1998, CANCER RES, V58, P4324
[7]   Antibody phage display technology and its applications [J].
Hoogenboom, HR ;
de Bruine, AP ;
Hufton, SE ;
Hoet, RM ;
Arends, JW ;
Roovers, RC .
IMMUNOTECHNOLOGY, 1998, 4 (01) :1-20
[8]   A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments [J].
Huls, GA ;
Heijnen, IAFM ;
Cuomo, ME ;
Koningsberger, JC ;
Wiegman, L ;
Boel, E ;
de Vries, ARV ;
Loyson, SAJ ;
Helfrich, W ;
Henegouwen, GPV ;
van Meijer, M ;
de Kruif, J ;
Logtenberg, T .
NATURE BIOTECHNOLOGY, 1999, 17 (03) :276-281
[9]   An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFV)-ETA′) is a potent immunotoxin against a Hodgkin-derived cell line [J].
Klimka, A ;
Barth, S ;
Matthey, B ;
Roovers, RC ;
Lemke, H ;
Hansen, H ;
Arends, JW ;
Diehl, V ;
Hoogenboom, HR ;
Engert, A .
BRITISH JOURNAL OF CANCER, 1999, 80 (08) :1214-1222
[10]  
Kupsch JM, 1999, CLIN CANCER RES, V5, P925